Structural basis for recognition of 2′,5′-linked oligoadenylates by human ribonuclease L

被引:74
|
作者
Tanaka, N
Nakanishi, M
Kusakabe, Y
Goto, Y
Kitade, Y
Nakamura, KT
机构
[1] Showa Univ, Sch Pharmaceut Sci, Shinagawa Ku, Tokyo 1428555, Japan
[2] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 50111, Japan
来源
EMBO JOURNAL | 2004年 / 23卷 / 20期
关键词
2-5A system; ankyrin repeat; crystal structure; drug design; interferon;
D O I
10.1038/sj.emboj.7600420
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An interferon-induced endoribonuclease, ribonuclease L (RNase L), is implicated in both the molecular mechanism of action of interferon and the fundamental control of RNA stability in mammalian cells. RNase L is catalytically active only after binding to an unusual activator molecule containing a 50-phosphorylated 20,50-linked oligoadenylate (2-5A), in the N-terminal half. Here, we report the crystal structure of the N-terminal ankyrin repeat domain (ANK) of human RNase L complexed with the activator 2-5A. This is the first structural view of an ankyrin repeat structure directly interacting with a nucleic acid, rather than with a protein. The ANK domain folds into eight ankyrin repeat elements and forms an extended curved structure with a concave surface. The 2-5A molecule is accommodated at a concave site and directly interacts with ankyrin repeats 2-4. Interestingly, two structurally equivalent 2-5A binding motifs are found at repeats 2 and 4. The structural basis for 2-5A recognition by ANK is essential for designing stable 2-5As with a high likelihood of activating RNase L.
引用
收藏
页码:3929 / 3938
页数:10
相关论文
共 50 条
  • [1] Recognition of 2′,5′-linked oligoadenylates by human ribonuclease L: molecular dynamics study
    Malac, Kamil
    Barvik, Ivan
    JOURNAL OF MOLECULAR MODELING, 2014, 20 (04)
  • [2] Recognition of 2′,5′-linked oligoadenylates by human ribonuclease L: molecular dynamics study
    Kamil Maláč
    Ivan Barvík
    Journal of Molecular Modeling, 2014, 20
  • [3] 2-methyladenosine-substituted 2′,5′-oligoadenylates:: Conformations, 2-5A binding and catalytic activities with human ribonuclease L
    Kitade, Y
    Wakana, M
    Tsuboi, T
    Yatome, C
    Bayly, SF
    Player, MR
    Torrence, PF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (04) : 329 - 331
  • [4] PRACTICAL SYNTHESIS OF 2'-5'-LINKED OLIGOADENYLATES (2-5A OLIGOMERS)
    NOYORI, R
    UCHIYAMA, M
    NOBORI, T
    HIROSE, M
    HAYAKAWA, Y
    AUSTRALIAN JOURNAL OF CHEMISTRY, 1992, 45 (01) : 205 - 225
  • [5] PURINE 8-SUBSTITUTION MODULATES THE RIBONUCLEASE-L BINDING AND ACTIVATION ABILITIES OF 2',5'-OLIGOADENYLATES
    KANOU, M
    OHOMORI, H
    NAGAI, K
    YOKOYAMA, S
    SUHADOLNIK, RJ
    SOBOL, R
    TAKAKU, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (02) : 769 - 774
  • [6] Monitoring activation of ribonuclease L by 2′,5′-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells
    Rusch, L
    Dong, BH
    Silverman, RH
    RIBONUCLEASES, PT B, 2001, 342 : 10 - 20
  • [7] Activation of human RNase L by 2′- and 5′-O-methylphosphonate- modified oligoadenylates
    Pav, Ondrej
    Panova, Natalya
    Snasel, Jan
    Zbornikova, Eva
    Rosenberg, Ivan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 181 - 185
  • [8] ENZYMATIC-SYNTHESIS OF (2'-5')-LINKED OLIGOADENYLATES ON A PREPARATIVE SCALE
    SAMANTA, H
    LENGYEL, P
    METHODS IN ENZYMOLOGY, 1986, 119 : 516 - 521
  • [9] STRUCTURAL BASIS FOR THE RECOGNITION OF ANGIOGENIN BY PLACENTAL RIBONUCLEASE INHIBITOR, A LRR PROTEIN
    Papageorgiou, A. C.
    Acharya, K. R.
    Shapiro, R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 44 - 44
  • [10] Activation of RNase L by 2',5'-oligoadenylates - Kinetic characterization
    Carroll, SS
    Cole, JL
    Viscount, T
    Geib, J
    Gehman, J
    Kuo, LC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) : 19193 - 19198